| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), OABI's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.42M | - | - | |
| Dir | 2.96M | - | - | |
| Other | 399.1K | - | - | |
| CFO | 261.5K | - | - | |
| Dir | 185.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Foehr Matthew W71 | President and CEO | Sale+OE | 19,244 | $1.49 | $28,673.56 | -0.4% | +59.6% | - | |
| Apr 7, 2026 | Gustafson Kurt A78 | Executive VP, Finance and CFO | Sale+OE | 6,913 | $1.49 | $10,300.37 | -2.6% | +59.6% | - | |
| Apr 7, 2026 | Berkman Charles S82 | Chief Legal Officer | Sale+OE | 7,157 | $1.49 | $10,663.93 | -1.8% | +59.6% | - | |
| Feb 18, 2026 | Foehr Matthew W71 | President and CEO | Sale+OE | 30,843 | $1.71 | $52,741.53 | -0.7% | +38.6% | - | |
| Feb 18, 2026 | Berkman Charles S82 | Chief Legal Officer | Sale+OE | 9,673 | $1.71 | $16,540.83 | -2.4% | +38.6% | - | |
| Feb 18, 2026 | Gustafson Kurt A78 | Executive VP, Finance and CFO | Sale+OE | 9,301 | $1.71 | $15,904.71 | -3.3% | +38.6% | - | |
| Feb 17, 2026 | Foehr Matthew W71 | President and CEO | Sale+OE | 20,754 | $1.70 | $35,281.80 | -0.5% | +33.9% | - | |
| Feb 17, 2026 | Gustafson Kurt A78 | Executive VP, Finance and CFO | Sale+OE | 6,828 | $1.70 | $11,607.60 | -2.6% | +33.9% | - | |
| Feb 17, 2026 | Berkman Charles S82 | Chief Legal Officer | Sale+OE | 6,990 | $1.70 | $11,883.00 | -1.8% | +33.9% | - | |
| Dec 8, 2025 | Gustafson Kurt A78 | Executive VP, Finance and CFO | Sale+OE | 23,922 | $1.96 | $46,887.12 | -8.6% | -2.0% | - |